tiprankstipranks
Trending News
More News >
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Income Statement

Compare
298 Followers

Lyra Therapeutics Income Statement

Last quarter (Q3 2024), Lyra Therapeutics's total revenue was $195.00K, a decrease of -64.15% from the same quarter last year. In Q3, Lyra Therapeutics's net income was $-11.87M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.53M$ 1.56M$ 1.36M$ 285.00K$ 0.00
Gross Profit
$ 1.53M$ 1.56M$ 296.00K$ -716.00K$ -95.00K
Operating Expenses
$ 97.88M$ 68.68M$ 56.35M$ 43.90M$ 22.21M
Depreciation and Amortization
$ 0.00$ 278.00K$ 1.07M$ 1.00M$ 95.00K
EBITDA
$ -96.35M$ -65.25M$ -53.92M$ -42.61M$ -22.11M
Operating Income
$ -96.35M$ -67.12M$ -56.31M$ -43.62M$ -22.21M
Other Income/Expenses
$ 2.95M$ 4.50M$ 1.04M$ 102.00K$ 82.00K
Pretax Income
$ -93.40M$ -62.62M$ -55.27M$ -43.51M$ -22.13M
Net Income
$ -93.44M$ -62.68M$ -55.28M$ -42.41M$ -22.05M
Per Share Metrics
Basic EPS
$ -1.43$ -1.26$ -1.83$ -3.27$ -2.57
Diluted EPS
$ -1.43$ -1.26$ -1.83$ -3.27$ -2.57
Weighted Average Shares Outstanding
65.11M 49.80M 30.24M 12.99M 8.59M
Weighted Average Shares Outstanding (Diluted)
65.11M 49.80M 30.24M 12.99M 8.59M
Currency in USD

Lyra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis